Flufenamic Acid, a Promising Agent for the Sensitization of Colistin-Resistant Gram-Negative Bacteria to Colistin
Open Access
- 13 April 2023
- journal article
- research article
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 11 (2) , e0405222
Abstract
Colistin is a last-line antibiotic used for the treatment of MDR Gram-negative bacterial infections. However, increasing resistance to it has been observed during clinical treatment.Keywords
Funding Information
- Key Laboratory of Clinical Laboratory Diagnosis and Translation Research of Zhejiang Province (2022E10022)
- Planned Science and Technology Project of Wenzhou (Y20170204)
This publication has 45 references indexed in Scilit:
- Identification of Potential Therapeutics to Conquer Drug Resistance in Salmonella typhimurium: Drug Repurposing StrategyBioDrugs, 2016
- Relationship between Antibiotic Resistance, Biofilm Formation, and Biofilm-Specific Resistance in Acinetobacter baumanniiFrontiers in Microbiology, 2016
- Membrane-Active Macromolecules Resensitize NDM-1 Gram-Negative Clinical Isolates to Tetracycline AntibioticsPLOS ONE, 2015
- Antimicrobial activity of essential oils and carvacrol, and synergy of carvacrol and erythromycin, against clinical, erythromycin-resistant Group A StreptococciFrontiers in Microbiology, 2015
- In vitro analysis of flufenamic acid activity against Candida albicans biofilmsInternational Journal of Antimicrobial Agents, 2014
- Flufenamic acid as an ion channel modulatorPharmacology & Therapeutics, 2013
- Flufenamic acid promotes angiogenesis through AMPK activationInternational Journal of Oncology, 2013
- Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time–kill assayInternational Journal of Antimicrobial Agents, 2011
- Multidrug-resistant Gram-negative bacteria: how to treat and for how longInternational Journal of Antimicrobial Agents, 2010
- Biofilms: Survival Mechanisms of Clinically Relevant MicroorganismsClinical Microbiology Reviews, 2002